NMR logo

Nomura Holdings (NMR) Cash from financing

annual CFF:

$11.03B+$4.01B(+57.11%)
March 1, 2025

Summary

  • As of today (May 23, 2025), NMR annual cash flow from financing activities is $11.03 billion, with the most recent change of +$4.01 billion (+57.11%) on March 1, 2025.
  • During the last 3 years, NMR annual CFF has risen by +$1.12 billion (+11.26%).
  • NMR annual CFF is now -52.99% below its all-time high of $23.46 billion, reached on March 31, 2010.

Performance

1-year change

+57.11%

3-year change

+11.26%

5-year change

+260.94%

15-year change

+227.42%

NMR Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.73%
NMR annual cash flow from financing activities is higher than 98.73% of companies in Financial Services sector

Range

All-time high

$23.46B
NMR annual cash flow from financing activities is currently -52.99% below its historical high of $23.46 billion

3-year low

$7.02B
NMR annual cash flow from financing activities is currently +57.11% above its 3-year low

Earnings dates

Last annual earnings report date

Mar 1, 2025
NMR previous annual earnings announcement was published on Mar 1, 2025

Next annual earnings report date

N/A
NMR next annual earnings announcement has not yet been scheduled

OtherNMRcash flow metrics

annual CFI

-$5.57B
NMR annual cash flow from investing activities is -$5.57 billion

annual CFO

-$4.46B
NMR annual cash flow from operations is -$4.46 billion

annual FCF

-$5.70B
NMR annual free cash flow is -$5.70 billion

annual CAPEX

$1.25B
NMR annual capital expenditures is $1.25 billion

quarterly CFF:

N/A
March 1, 2025

Summary

  • NMR quarterly cash flow from financing activities is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

NMR quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$14.06B
NMR quarterly cash flow from financing activities is currently at an all-time high

3-year low

-$1.52B
NMR quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
NMR previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Jul 30, 2025
NMR next earnings announcement is scheduled for Jul 30, 2025

OtherNMRcash flow metrics

quarterly CFI

-
NMR quarterly cash flow from investing activities value is unknown

quarterly CFO

-
NMR quarterly cash flow from operations value is unknown

quarterly FCF

-
NMR quarterly free cash flow value is unknown

quarterly CAPEX

-
NMR quarterly capital expenditures value is unknown

TTM CFF:

N/A
March 1, 2025

Summary

  • NMR TTM cash flow from financing activities is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

NMR TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$34.95B
NMR TTM cash flow from financing activities is currently at an all-time high

3-year low

$5.08B
NMR TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
NMR previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Jul 30, 2025
NMR next earnings announcement is scheduled for Jul 30, 2025

OtherNMRcash flow metrics

TTM CFI

-
NMR TTM cash flow from investing activities value is unknown

TTM CFO

-
NMR TTM cash flow from operations value is unknown

TTM FCF

-
NMR TTM free cash flow value is unknown

TTM CAPEX

-
NMR TTM capital expenditures value is unknown

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NMR Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+57.1%--
3 y3 years+11.3%--
5 y5 years+260.9%--

NMR Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+57.1%
5 y5-yearat high+274.8%
alltimeall time-53.0%+156.0%

NMR Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
$11.03B(+57.1%)
-
-
Mar 2024
$7.02B(-26.2%)
$3.08B(+28.4%)
$7.02B(-6.8%)
Dec 2023
-
$2.40B(-22.0%)
$7.53B(+34.8%)
Sep 2023
-
$3.07B(-301.5%)
$5.59B(+10.0%)
Jun 2023
-
-$1.52B(-142.5%)
$5.08B(-46.6%)
Mar 2023
$9.51B(-4.1%)
$3.59B(+697.9%)
$9.51B(-3.7%)
Dec 2022
-
$449.95M(-82.5%)
$9.88B(-5.0%)
Sep 2022
-
$2.57B(-11.6%)
$10.40B(-3.8%)
Jun 2022
-
$2.90B(-26.7%)
$10.82B(+9.1%)
Mar 2022
$9.91B(-257.1%)
$3.96B(+306.6%)
$9.91B(+198.7%)
Dec 2021
-
$973.54M(-67.3%)
$3.32B(-481.0%)
Sep 2021
-
$2.98B(+49.1%)
-$870.83M(-59.7%)
Jun 2021
-
$2.00B(-175.9%)
-$2.16B(-65.7%)
Mar 2021
-$6.31B(-306.5%)
-$2.64B(-18.0%)
-$6.31B(-839.8%)
Dec 2020
-
-$3.22B(-290.2%)
$852.69M(-70.2%)
Sep 2020
-
$1.69B(-178.7%)
$2.86B(+2.7%)
Jun 2020
-
-$2.15B(-147.5%)
$2.79B(-8.8%)
Mar 2020
$3.06B(-55.5%)
$4.53B(-475.5%)
$3.06B(+175.4%)
Dec 2019
-
-$1.21B(-174.7%)
$1.11B(-61.5%)
Sep 2019
-
$1.61B(-185.9%)
$2.88B(-22.3%)
Jun 2019
-
-$1.88B(-172.8%)
$3.71B(-46.0%)
Mar 2019
$6.87B(+103.9%)
$2.58B(+355.1%)
$6.87B(+44.1%)
Dec 2018
-
$566.85M(-76.8%)
$4.77B(+23.8%)
Sep 2018
-
$2.44B(+90.5%)
$3.85B(+90.8%)
Jun 2018
-
$1.28B(+166.9%)
$2.02B(-40.1%)
Mar 2018
$3.37B(-117.1%)
$479.63M(-237.8%)
$3.37B(+722.6%)
Dec 2017
-
-$348.06M(-157.4%)
$409.42M(-269.4%)
Sep 2017
-
$606.70M(-76.9%)
-$241.75M(-96.5%)
Jun 2017
-
$2.63B(-206.1%)
-$6.94B(-64.8%)
Mar 2017
-$19.70B(-339.7%)
-$2.48B(+148.1%)
-$19.70B(+146.2%)
Dec 2016
-
-$999.23M(-83.6%)
-$8.00B(-6.5%)
Sep 2016
-
-$6.09B(-39.9%)
-$8.55B(+392.4%)
Jun 2016
-
-$10.13B(-209.9%)
-$1.74B(-121.1%)
Mar 2016
$8.22B(-604.4%)
$9.22B(-694.1%)
$8.22B(-1388.7%)
Dec 2015
-
-$1.55B(-314.1%)
-$637.84M(-395.5%)
Sep 2015
-
$724.96M(-515.7%)
$215.85M(-135.5%)
Jun 2015
-
-$174.40M(-147.9%)
-$608.37M(-62.7%)
Mar 2015
-$1.63B(-156.4%)
$363.95M(-152.1%)
-$1.63B(-247.6%)
Dec 2014
-
-$698.65M(+603.8%)
$1.10B(-1058.4%)
Sep 2014
-
-$99.26M(-91.7%)
-$115.24M(-95.9%)
Jun 2014
-
-$1.20B(-138.6%)
-$2.78B(-196.2%)
Mar 2014
$2.89B(-134.0%)
$3.10B(-261.5%)
$2.89B(-208.7%)
Dec 2013
-
-$1.92B(-30.6%)
-$2.66B(+444.9%)
Sep 2013
-
-$2.76B(-161.8%)
-$487.97M(-85.8%)
Jun 2013
-
$4.47B(-282.6%)
-$3.43B(-59.6%)
Mar 2013
-$8.49B
-$2.45B(-1070.4%)
-$8.49B(-31.2%)
DateAnnualQuarterlyTTM
Dec 2012
-
$252.47M(-104.4%)
-$12.34B(-15.6%)
Sep 2012
-
-$5.70B(+866.5%)
-$14.63B(+58.3%)
Jun 2012
-
-$589.99M(-90.6%)
-$9.24B(-13.6%)
Mar 2012
-$10.70B(-171.7%)
-$6.30B(+209.4%)
-$10.70B(+2910.9%)
Dec 2011
-
-$2.04B(+553.6%)
-$355.28M(-112.7%)
Sep 2011
-
-$311.67M(-84.8%)
$2.80B(-335.8%)
Jun 2011
-
-$2.05B(-150.6%)
-$1.19B(-108.0%)
Mar 2011
$14.92B(-36.4%)
$4.04B(+260.4%)
$14.92B(-16.3%)
Dec 2010
-
$1.12B(-126.0%)
$17.81B(-33.2%)
Sep 2010
-
-$4.30B(-130.6%)
$26.68B(-23.6%)
Jun 2010
-
$14.06B(+102.6%)
$34.95B(+49.0%)
Mar 2010
$23.46B(+133.3%)
$6.94B(-30.5%)
$23.46B(+8.5%)
Dec 2009
-
$9.99B(+152.1%)
$21.61B(+65.7%)
Sep 2009
-
$3.96B(+54.2%)
$13.04B(+83.9%)
Jun 2009
-
$2.57B(-49.5%)
$7.09B(-29.5%)
Mar 2009
$10.05B(+21.5%)
$5.09B(+259.4%)
$10.05B(+105.0%)
Dec 2008
-
$1.42B(-171.2%)
$4.90B(+81.8%)
Sep 2008
-
-$1.99B(-135.9%)
$2.70B(-70.8%)
Jun 2008
-
$5.54B(-9375.6%)
$9.24B(+11.7%)
Mar 2008
$8.27B(-38.5%)
-$59.68M(-92.4%)
$8.27B(-41.4%)
Dec 2007
-
-$790.31M(-117.3%)
$14.11B(-6.6%)
Sep 2007
-
$4.56B(-0.2%)
$15.11B(+76.9%)
Jun 2007
-
$4.57B(-21.0%)
$8.54B(-36.5%)
Mar 2007
$13.45B(+93.1%)
$5.78B(+2697.7%)
$13.45B(+91.9%)
Dec 2006
-
$206.58M(-110.3%)
$7.01B(-23.8%)
Sep 2006
-
-$2.01B(-121.2%)
$9.19B(-42.1%)
Jun 2006
-
$9.48B(-1536.0%)
$15.89B(+128.1%)
Mar 2006
$6.97B(+94.0%)
-$659.92M(-127.6%)
$6.97B(-11.8%)
Dec 2005
-
$2.39B(-48.9%)
$7.90B(+16.3%)
Sep 2005
-
$4.68B(+741.5%)
$6.79B(-32.3%)
Jun 2005
-
$555.97M(+102.8%)
$10.03B(+179.3%)
Mar 2005
$3.59B(-79.2%)
$274.11M(-78.6%)
$3.59B(-70.6%)
Dec 2004
-
$1.28B(-83.8%)
$12.22B(-33.4%)
Sep 2004
-
$7.92B(-234.6%)
$18.35B(+48.8%)
Jun 2004
-
-$5.88B(-166.1%)
$12.33B(-28.6%)
Mar 2004
$17.27B(-8668.9%)
$8.90B(+20.1%)
$17.27B(+65.8%)
Dec 2003
-
$7.41B(+289.9%)
$10.42B(-1318.3%)
Sep 2003
-
$1.90B(-302.7%)
-$854.98M(-31.6%)
Jun 2003
-
-$937.60M(-145.9%)
-$1.25B(+520.3%)
Mar 2003
-$201.58M(-102.1%)
$2.04B(-152.9%)
-$201.58M(-91.0%)
Dec 2002
-
-$3.86B(-356.4%)
-$2.24B(-238.8%)
Sep 2002
-
$1.51B(+1253.4%)
$1.62B(+1353.4%)
Jun 2002
-
$111.23M
$111.23M
Mar 2002
$9.59B(-1143.8%)
-
-
Mar 2001
-$918.85M(+40.8%)
-
-
Mar 2000
-$652.72M
-
-

FAQ

  • What is Nomura Holdings annual cash flow from financing activities?
  • What is the all time high annual CFF for Nomura Holdings?
  • What is Nomura Holdings annual CFF year-on-year change?
  • What is the all time high quarterly CFF for Nomura Holdings?
  • What is the all time high TTM CFF for Nomura Holdings?

What is Nomura Holdings annual cash flow from financing activities?

The current annual CFF of NMR is $11.03B

What is the all time high annual CFF for Nomura Holdings?

Nomura Holdings all-time high annual cash flow from financing activities is $23.46B

What is Nomura Holdings annual CFF year-on-year change?

Over the past year, NMR annual cash flow from financing activities has changed by +$4.01B (+57.11%)

What is the all time high quarterly CFF for Nomura Holdings?

Nomura Holdings all-time high quarterly cash flow from financing activities is $14.06B

What is the all time high TTM CFF for Nomura Holdings?

Nomura Holdings all-time high TTM cash flow from financing activities is $34.95B
On this page